An Integrated Phase I/II, Multicentre, Double-Blind, Randomised, Dysport and Placebo Controlled, Dose-Escalation and Dose-Findin

An Integrated Phase I/II, Multicentre, Double-Blind, Randomised, Dysport and Placebo Controlled, Dose-Escalation and Dose-Finding Study to Evaluate the Safety and Efficacy of IPN10200 in the Treatment of Adult Upper Limb Spasticity Followed by an Open-label Extension Period.

Open

Protocol code: D-FR-10200-001
EudraCT code: 2020-003623-42
Research group: Research Group of Physical Medicine and Rehabilitation
Service: Rehabilitation
Principal investigator: Rodriguez Gonzalez, Susana
Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Phase: Fase II
Status: Recruiting volunteers